{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"semax-herniated-disc","urls":{"read":"https://miscsubjects.com/api/articles/semax-herniated-disc/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/semax-herniated-disc/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/semax-herniated-disc/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/semax-herniated-disc/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/semax-herniated-disc/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/semax-herniated-disc/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/semax-herniated-disc/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"semax-herniated-disc","title":"Semax for Herniated Disc: Neural Repair Pathways and Evidence Layers","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:54.531Z","body_excerpt":"## What's breaking down if you have Herniated disc\n\nA herniation occurs when disc material pushes through the outer ring. It often starts from degenerative disc changes where a weakened annulus tears under load. The herniation is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain while the disc structure remains compromised.\n\nDegenerative layers include:\n- Disc matrix: Collagen and proteoglycans degrade; disc height drops.\n- Inflammation: Chronic inflammatory signaling without resolution stalls repair.\n- Nerves: Nerve roots get irritated or compressed as the disc bulges.\n- Blood supply: Discs are avascular — repair depends on diffusion; less supply slows repair.\n\nBreakdown outruns repair. The condition persists.\n\n## Why Semax might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **What keeps failing:** BDNF decline, neural stress, cognitive fatigue.\n3. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. **Therefore for you:** If the neural layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n5. This article centers **Semax**; see other sections for BPC-157, TB-500, ARA-290 — different layers, same condition.\n\n## Why BPC-157 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Inflammation — Chronic inflammatory signaling without resolution stalls repair.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Nerves — Nerve roots get irritated or compressed as disc bulges.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\n## How these fit together\n\nThree degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.\n- **Semax** → neural / cognitive\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\nPrimary focus of this slug: **Semax**. Others are in scope because the same condition breaks down on multiple layers.\n\n## What the evidence actually shows\n\nHuman data on Semax comes from a 2018 study of 110 ischemic stroke patients where Semax raised plasma BDNF levels and improved motor recovery and Barthel index scores regardless of rehabilitation timing (human). No human trials exist for Semax in herniated disc or disc degeneration. Preclinical work shows Semax activates neurotrophin transcription in rat models (preclinical). BPC-157, TB-500, and ARA-290 have no published human trials for herniated disc (human: none). BPC-157 shows tissue and nerve effects in rat spinal cord injury models (preclinical). TB-500 improved outcomes in rat spinal cord compression via anti-inflammatory and vasculoprotective effects (preclinical). ARA-290 demons","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"A 2018 study of 110 ischemic stroke patients found Semax increased plasma BDNF levels and improved motor performance and Barthel index scores.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the only direct human data on Semax BDNF effects; supports neural repair discussion for the reader.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c2","text":"No published human trials exist for Semax, BPC-157, TB-500, or ARA-290 in herniated disc or disc degeneration.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Sets clear evidence boundary so reader understands mechanistic vs clinical status.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"ARA-290 produced small nerve fiber regrowth in cornea and improved neuropathic symptoms in human sarcoidosis and type 2 diabetes patients.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s4"],"source_status":"sourced","why_material":"Only human nerve repair data among the peptides; directly relevant to nerve layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"BPC-157 and TB-500 show tissue repair, angiogenesis, and anti-inflammatory effects in rat spinal cord injury and nerve models.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Grounds the structure and inflammation layer discussions in actual animal findings.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period. ... Early rehabilitation and administration of semax increase BDNF plasma level, speed functional recovery, and improve motor performance.","summary":"110-patient human trial showing Semax raises BDNF and aids stroke recovery.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"dad048f980d6eb8992e241a8606f9b887b2933c82955ea342b07df9e5154ff8b"},{"id":"s2","type":"other","url":"https://friscorehab.com/can-bpc-157-heal-a-herniated-disc-what-patients-with-back-pain-should-know/","title":"Can BPC-157 Heal a Herniated Disc?","quote":"However, there is currently no strong clinical evidence showing BPC-157 can repair or reverse a herniated disc in humans.","summary":"Review stating lack of human disc data for BPC-157.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"12f6a61d80678f89985995d9e42e6fe832c5a8d16507fae606d87a8f0b36f02f"},{"id":"s3","type":"other","url":"https://www.redfoxpeptides.is/bpc-157-disc-herniation-lower-back-pain/","title":"BPC-157: Disc Herniation & Lower Back Pain","quote":"Direct human studies on bpc 157 herniated disc research are not yet available.","summary":"Confirms absence of human herniated disc trials.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"7036b87a7380b13c76aa40062779200000ac84e4ba13de427edacdf09a9fe940"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"In patients with sarcoidosis, ARA290 significantly improved neuropathic and autonomic symptoms... initiated a regrowth of small nerve fibers in the cornea.","summary":"Human clinical data on ARA-290 for neuropathy and nerve fiber regrowth.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"898917ee7b3d0b7023266d2734850fd457ccf33d62e9971a77fd2e150cc26b13"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats","quote":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats.","summary":"Rat spinal cord injury study supporting BPC-157 repair effects.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"4cd1cbace923c07ce2923efbc4645d6c210b325b263e8076e73abd5b527d219d"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/24937047/","title":"Beneficial effects of thymosin β4 on spinal cord injury in the rat","quote":"All behavioral assessments were markedly improved with Tβ4 treatment... numbers of surviving neurons and oligodendrocytes were significantly increased.","summary":"Rat study on TB-500/Thymosin beta-4 for spinal cord injury recovery.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"b901358d927858b33e44c93f01b89398820760f0065d8235018f6aaf0174e12c"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period. ... Early rehabilitation and administration of semax increase BDNF plasma level, speed functional recovery, and improve motor performance.","summary":"110-patient human trial showing Semax raises BDNF and aids stroke recovery.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"dad048f980d6eb8992e241a8606f9b887b2933c82955ea342b07df9e5154ff8b"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"In patients with sarcoidosis, ARA290 significantly improved neuropathic and autonomic symptoms... initiated a regrowth of small nerve fibers in the cornea.","summary":"Human clinical data on ARA-290 for neuropathy and nerve fiber regrowth.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"898917ee7b3d0b7023266d2734850fd457ccf33d62e9971a77fd2e150cc26b13"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats","quote":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats.","summary":"Rat spinal cord injury study supporting BPC-157 repair effects.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"4cd1cbace923c07ce2923efbc4645d6c210b325b263e8076e73abd5b527d219d"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/24937047/","title":"Beneficial effects of thymosin β4 on spinal cord injury in the rat","quote":"All behavioral assessments were markedly improved with Tβ4 treatment... numbers of surviving neurons and oligodendrocytes were significantly increased.","summary":"Rat study on TB-500/Thymosin beta-4 for spinal cord injury recovery.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"b901358d927858b33e44c93f01b89398820760f0065d8235018f6aaf0174e12c"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"semax-herniated-disc","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":6,"anecdotal":0,"scientific":4,"user_reports":0,"questions":0,"evidence_ingests":0}}